Rare bovine brain tumor detailed in new ependymoma case report

Intracerebral papillary ependymoma in a cow

A new case report in the Journal of Veterinary Diagnostic Investigation describes an intracerebral papillary ependymoma in a 7.5-year-old cow that had initially been investigated as a bovine spongiform encephalopathy suspect. The authors say intracranial neoplasms are rare in cattle, and bovine ependymomas have only been reported sporadically, with little detailed morphologic description and, to their knowledge, no prior immunohistochemical characterization. In this case, the mass was a large, well-demarcated intraparenchymal lesion in the left cerebral hemisphere, and the report focused on its gross, histologic, and immunophenotypic features. That matters because neurologic cattle submitted as possible BSE cases can ultimately prove to have uncommon structural brain disease instead. (woah.org)

Why it matters: For veterinary diagnosticians and neurologists, the report adds a more complete reference point for differentiating rare bovine CNS tumors from other neurologic differentials, including reportable prion disease. A 2022 retrospective series found intracranial neoplasms in cattle are uncommon and diverse, with gliomas, meningiomas, metastatic carcinomas, medulloblastomas, and choroid plexus carcinoma represented; that study also highlighted how immunohistochemistry can help separate papillary-pattern tumors that may look similar on routine histology. Merck likewise notes that definitive antemortem diagnosis of intracranial neoplasia in cattle is rare and prognosis is poor, which makes well-documented pathology cases especially useful for diagnostic labs and referral centers. (pubmed.ncbi.nlm.nih.gov)

What to watch: Watch for whether this case is incorporated into future bovine neuropathology reviews and diagnostic guidance as another reminder that rare tumors can sit on the differential list for adult cattle with progressive neurologic signs, especially in BSE-ruleout workups. (journals.sagepub.com)

Read the full analysis →

Like what you're reading?

The Feed delivers veterinary news every weekday.